Citadel Advisors »

Indaptus Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Indaptus Therapeutics (INDP) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Indaptus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Indaptus Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Indaptus Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $29k 17k 1.77
2021-09-30 $111k 14k 7.80

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Broadcom Call Option (AVGO)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl C Call Option (GOOG)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl A Call Option (GOOGL)

View all positions for Citadel Advisors

Top funds holding Indaptus Therapeutics

Vanguard Group
Investment House
Geode Capital Management
Strategy Asset Managers
Pine Valley Investments Ltd Liability
Vivaldi Capital Management
Tower Research Capital
UBS Group
Morgan Stanley
Bangor Savings Bank
Wells Fargo & Company
Jpmorgan Chase & Co
Group One Trading
Qube Research & Technologies

View all funds holding Indaptus Therapeutics